nodes	percent_of_prediction	percent_of_DWPC	metapath
Epoprostenol—PTGIS—endothelium—malignant glioma	0.0441	0.19	CbGeAlD
Epoprostenol—PTGIS—blood vessel—malignant glioma	0.0407	0.175	CbGeAlD
Epoprostenol—PTGIR—endothelium—malignant glioma	0.0253	0.109	CbGeAlD
Epoprostenol—PTGIR—blood vessel—malignant glioma	0.0234	0.101	CbGeAlD
Epoprostenol—PTGIR—brainstem—malignant glioma	0.0128	0.055	CbGeAlD
Epoprostenol—PTGIR—telencephalon—malignant glioma	0.0113	0.0488	CbGeAlD
Epoprostenol—PTGIS—central nervous system—malignant glioma	0.0112	0.0483	CbGeAlD
Epoprostenol—PTGER1—central nervous system—malignant glioma	0.0104	0.0449	CbGeAlD
Epoprostenol—P2RY12—central nervous system—malignant glioma	0.0101	0.0435	CbGeAlD
Epoprostenol—PTGIS—brain—malignant glioma	0.00891	0.0384	CbGeAlD
Epoprostenol—P2RY12—brain—malignant glioma	0.00802	0.0346	CbGeAlD
Epoprostenol—PTGIR—spinal cord—malignant glioma	0.00794	0.0342	CbGeAlD
Epoprostenol—Influenza-like symptoms—Temozolomide—malignant glioma	0.00784	0.0249	CcSEcCtD
Epoprostenol—Hyperaesthesia—Temozolomide—malignant glioma	0.00714	0.0227	CcSEcCtD
Epoprostenol—Injection site pain—Carmustine—malignant glioma	0.0071	0.0226	CcSEcCtD
Epoprostenol—Endocrine disorder—Temozolomide—malignant glioma	0.00676	0.0215	CcSEcCtD
Epoprostenol—PTGIR—central nervous system—malignant glioma	0.00644	0.0278	CbGeAlD
Epoprostenol—PTGIR—cerebellum—malignant glioma	0.0063	0.0271	CbGeAlD
Epoprostenol—Neck pain—Carmustine—malignant glioma	0.00587	0.0187	CcSEcCtD
Epoprostenol—Pulmonary embolism—Carmustine—malignant glioma	0.0058	0.0184	CcSEcCtD
Epoprostenol—Injection site reaction—Carmustine—malignant glioma	0.00576	0.0183	CcSEcCtD
Epoprostenol—Musculoskeletal pain—Temozolomide—malignant glioma	0.00567	0.018	CcSEcCtD
Epoprostenol—Pulmonary embolism—Temozolomide—malignant glioma	0.0056	0.0178	CcSEcCtD
Epoprostenol—Influenza like illness—Temozolomide—malignant glioma	0.00544	0.0173	CcSEcCtD
Epoprostenol—PTGIR—brain—malignant glioma	0.00512	0.022	CbGeAlD
Epoprostenol—Sepsis—Carmustine—malignant glioma	0.00503	0.016	CcSEcCtD
Epoprostenol—Hepatic failure—Temozolomide—malignant glioma	0.00453	0.0144	CcSEcCtD
Epoprostenol—Thirst—Temozolomide—malignant glioma	0.00427	0.0136	CcSEcCtD
Epoprostenol—Abdominal distension—Temozolomide—malignant glioma	0.00354	0.0113	CcSEcCtD
Epoprostenol—Pancytopenia—Carmustine—malignant glioma	0.00345	0.011	CcSEcCtD
Epoprostenol—Pancytopenia—Temozolomide—malignant glioma	0.00334	0.0106	CcSEcCtD
Epoprostenol—Pneumonia—Carmustine—malignant glioma	0.00326	0.0104	CcSEcCtD
Epoprostenol—Depression—Carmustine—malignant glioma	0.00323	0.0103	CcSEcCtD
Epoprostenol—Weight decreased—Temozolomide—malignant glioma	0.00318	0.0101	CcSEcCtD
Epoprostenol—Urinary tract infection—Carmustine—malignant glioma	0.00315	0.01	CcSEcCtD
Epoprostenol—Pneumonia—Temozolomide—malignant glioma	0.00315	0.01	CcSEcCtD
Epoprostenol—Infestation NOS—Temozolomide—malignant glioma	0.00313	0.00996	CcSEcCtD
Epoprostenol—Infestation—Temozolomide—malignant glioma	0.00313	0.00996	CcSEcCtD
Epoprostenol—Depression—Temozolomide—malignant glioma	0.00312	0.00994	CcSEcCtD
Epoprostenol—Urinary tract infection—Temozolomide—malignant glioma	0.00305	0.00969	CcSEcCtD
Epoprostenol—Sinusitis—Temozolomide—malignant glioma	0.00294	0.00935	CcSEcCtD
Epoprostenol—Haemoglobin—Carmustine—malignant glioma	0.00293	0.0093	CcSEcCtD
Epoprostenol—Haemorrhage—Carmustine—malignant glioma	0.00291	0.00926	CcSEcCtD
Epoprostenol—Hypoaesthesia—Carmustine—malignant glioma	0.0029	0.00921	CcSEcCtD
Epoprostenol—Oedema peripheral—Carmustine—malignant glioma	0.00287	0.00912	CcSEcCtD
Epoprostenol—Connective tissue disorder—Carmustine—malignant glioma	0.00286	0.0091	CcSEcCtD
Epoprostenol—Haemoglobin—Temozolomide—malignant glioma	0.00283	0.00899	CcSEcCtD
Epoprostenol—Haemorrhage—Temozolomide—malignant glioma	0.00281	0.00894	CcSEcCtD
Epoprostenol—Hypoaesthesia—Temozolomide—malignant glioma	0.0028	0.0089	CcSEcCtD
Epoprostenol—Pharyngitis—Temozolomide—malignant glioma	0.00279	0.00888	CcSEcCtD
Epoprostenol—Oedema peripheral—Temozolomide—malignant glioma	0.00277	0.00881	CcSEcCtD
Epoprostenol—Connective tissue disorder—Temozolomide—malignant glioma	0.00276	0.00879	CcSEcCtD
Epoprostenol—Flushing—Carmustine—malignant glioma	0.0027	0.00859	CcSEcCtD
Epoprostenol—Cardiac disorder—Temozolomide—malignant glioma	0.00261	0.0083	CcSEcCtD
Epoprostenol—Flushing—Temozolomide—malignant glioma	0.00261	0.0083	CcSEcCtD
Epoprostenol—Angiopathy—Temozolomide—malignant glioma	0.00255	0.00812	CcSEcCtD
Epoprostenol—Mental disorder—Carmustine—malignant glioma	0.00255	0.00811	CcSEcCtD
Epoprostenol—Mediastinal disorder—Temozolomide—malignant glioma	0.00254	0.00806	CcSEcCtD
Epoprostenol—Chills—Temozolomide—malignant glioma	0.00252	0.00803	CcSEcCtD
Epoprostenol—Mental disorder—Temozolomide—malignant glioma	0.00246	0.00784	CcSEcCtD
Epoprostenol—Back pain—Carmustine—malignant glioma	0.00245	0.00779	CcSEcCtD
Epoprostenol—Tremor—Carmustine—malignant glioma	0.00237	0.00755	CcSEcCtD
Epoprostenol—Back pain—Temozolomide—malignant glioma	0.00237	0.00753	CcSEcCtD
Epoprostenol—Anaemia—Carmustine—malignant glioma	0.00234	0.00745	CcSEcCtD
Epoprostenol—Agitation—Carmustine—malignant glioma	0.00233	0.0074	CcSEcCtD
Epoprostenol—Tremor—Temozolomide—malignant glioma	0.00229	0.0073	CcSEcCtD
Epoprostenol—Anaemia—Temozolomide—malignant glioma	0.00226	0.0072	CcSEcCtD
Epoprostenol—Agitation—Temozolomide—malignant glioma	0.00225	0.00716	CcSEcCtD
Epoprostenol—Palpitations—Temozolomide—malignant glioma	0.00216	0.00688	CcSEcCtD
Epoprostenol—Chest pain—Carmustine—malignant glioma	0.00216	0.00686	CcSEcCtD
Epoprostenol—Myalgia—Carmustine—malignant glioma	0.00216	0.00686	CcSEcCtD
Epoprostenol—Anxiety—Carmustine—malignant glioma	0.00215	0.00684	CcSEcCtD
Epoprostenol—Cough—Temozolomide—malignant glioma	0.00214	0.00679	CcSEcCtD
Epoprostenol—Confusional state—Carmustine—malignant glioma	0.00209	0.00663	CcSEcCtD
Epoprostenol—Arthralgia—Temozolomide—malignant glioma	0.00208	0.00663	CcSEcCtD
Epoprostenol—Myalgia—Temozolomide—malignant glioma	0.00208	0.00663	CcSEcCtD
Epoprostenol—Anxiety—Temozolomide—malignant glioma	0.00208	0.00661	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00207	0.00658	CcSEcCtD
Epoprostenol—Oedema—Carmustine—malignant glioma	0.00207	0.00658	CcSEcCtD
Epoprostenol—Infection—Carmustine—malignant glioma	0.00205	0.00653	CcSEcCtD
Epoprostenol—Dry mouth—Temozolomide—malignant glioma	0.00204	0.00648	CcSEcCtD
Epoprostenol—Thrombocytopenia—Carmustine—malignant glioma	0.00203	0.00644	CcSEcCtD
Epoprostenol—Tachycardia—Carmustine—malignant glioma	0.00202	0.00642	CcSEcCtD
Epoprostenol—Confusional state—Temozolomide—malignant glioma	0.00202	0.00641	CcSEcCtD
Epoprostenol—Anaphylactic shock—Temozolomide—malignant glioma	0.002	0.00636	CcSEcCtD
Epoprostenol—Oedema—Temozolomide—malignant glioma	0.002	0.00636	CcSEcCtD
Epoprostenol—Infection—Temozolomide—malignant glioma	0.00199	0.00631	CcSEcCtD
Epoprostenol—Anorexia—Carmustine—malignant glioma	0.00197	0.00627	CcSEcCtD
Epoprostenol—Nervous system disorder—Temozolomide—malignant glioma	0.00196	0.00623	CcSEcCtD
Epoprostenol—Thrombocytopenia—Temozolomide—malignant glioma	0.00196	0.00622	CcSEcCtD
Epoprostenol—Skin disorder—Temozolomide—malignant glioma	0.00194	0.00617	CcSEcCtD
Epoprostenol—Hypotension—Carmustine—malignant glioma	0.00193	0.00614	CcSEcCtD
Epoprostenol—Hyperhidrosis—Temozolomide—malignant glioma	0.00193	0.00614	CcSEcCtD
Epoprostenol—Anorexia—Temozolomide—malignant glioma	0.00191	0.00606	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00188	0.00599	CcSEcCtD
Epoprostenol—Insomnia—Carmustine—malignant glioma	0.00187	0.00595	CcSEcCtD
Epoprostenol—Paraesthesia—Carmustine—malignant glioma	0.00186	0.0059	CcSEcCtD
Epoprostenol—Dyspnoea—Carmustine—malignant glioma	0.00184	0.00586	CcSEcCtD
Epoprostenol—Somnolence—Carmustine—malignant glioma	0.00184	0.00585	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00182	0.00579	CcSEcCtD
Epoprostenol—Insomnia—Temozolomide—malignant glioma	0.00181	0.00575	CcSEcCtD
Epoprostenol—Decreased appetite—Carmustine—malignant glioma	0.0018	0.00572	CcSEcCtD
Epoprostenol—Paraesthesia—Temozolomide—malignant glioma	0.00179	0.00571	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Carmustine—malignant glioma	0.00179	0.00568	CcSEcCtD
Epoprostenol—Dyspnoea—Temozolomide—malignant glioma	0.00178	0.00567	CcSEcCtD
Epoprostenol—Somnolence—Temozolomide—malignant glioma	0.00178	0.00565	CcSEcCtD
Epoprostenol—Constipation—Carmustine—malignant glioma	0.00177	0.00562	CcSEcCtD
Epoprostenol—Pain—Carmustine—malignant glioma	0.00177	0.00562	CcSEcCtD
Epoprostenol—Dyspepsia—Temozolomide—malignant glioma	0.00176	0.00559	CcSEcCtD
Epoprostenol—Decreased appetite—Temozolomide—malignant glioma	0.00174	0.00552	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00173	0.00549	CcSEcCtD
Epoprostenol—Fatigue—Temozolomide—malignant glioma	0.00172	0.00548	CcSEcCtD
Epoprostenol—Pain—Temozolomide—malignant glioma	0.00171	0.00543	CcSEcCtD
Epoprostenol—Constipation—Temozolomide—malignant glioma	0.00171	0.00543	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Carmustine—malignant glioma	0.00169	0.00538	CcSEcCtD
Epoprostenol—Body temperature increased—Carmustine—malignant glioma	0.00163	0.0052	CcSEcCtD
Epoprostenol—Abdominal pain—Carmustine—malignant glioma	0.00163	0.0052	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Temozolomide—malignant glioma	0.00163	0.0052	CcSEcCtD
Epoprostenol—Urticaria—Temozolomide—malignant glioma	0.00159	0.00505	CcSEcCtD
Epoprostenol—Abdominal pain—Temozolomide—malignant glioma	0.00158	0.00502	CcSEcCtD
Epoprostenol—Body temperature increased—Temozolomide—malignant glioma	0.00158	0.00502	CcSEcCtD
Epoprostenol—Hypersensitivity—Carmustine—malignant glioma	0.00152	0.00485	CcSEcCtD
Epoprostenol—Asthenia—Carmustine—malignant glioma	0.00148	0.00472	CcSEcCtD
Epoprostenol—Hypersensitivity—Temozolomide—malignant glioma	0.00147	0.00468	CcSEcCtD
Epoprostenol—Asthenia—Temozolomide—malignant glioma	0.00143	0.00456	CcSEcCtD
Epoprostenol—Diarrhoea—Carmustine—malignant glioma	0.00142	0.0045	CcSEcCtD
Epoprostenol—Pruritus—Temozolomide—malignant glioma	0.00141	0.0045	CcSEcCtD
Epoprostenol—Dizziness—Carmustine—malignant glioma	0.00137	0.00435	CcSEcCtD
Epoprostenol—Diarrhoea—Temozolomide—malignant glioma	0.00137	0.00435	CcSEcCtD
Epoprostenol—Dizziness—Temozolomide—malignant glioma	0.00132	0.0042	CcSEcCtD
Epoprostenol—Vomiting—Carmustine—malignant glioma	0.00132	0.00418	CcSEcCtD
Epoprostenol—Rash—Carmustine—malignant glioma	0.0013	0.00415	CcSEcCtD
Epoprostenol—Dermatitis—Carmustine—malignant glioma	0.0013	0.00414	CcSEcCtD
Epoprostenol—Headache—Carmustine—malignant glioma	0.0013	0.00412	CcSEcCtD
Epoprostenol—Vomiting—Temozolomide—malignant glioma	0.00127	0.00404	CcSEcCtD
Epoprostenol—Rash—Temozolomide—malignant glioma	0.00126	0.00401	CcSEcCtD
Epoprostenol—Dermatitis—Temozolomide—malignant glioma	0.00126	0.004	CcSEcCtD
Epoprostenol—Headache—Temozolomide—malignant glioma	0.00125	0.00398	CcSEcCtD
Epoprostenol—Nausea—Carmustine—malignant glioma	0.00123	0.00391	CcSEcCtD
Epoprostenol—Nausea—Temozolomide—malignant glioma	0.00119	0.00377	CcSEcCtD
Epoprostenol—P2RY12—Signaling Pathways—NTRK1—malignant glioma	0.000217	0.000478	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—PTPN11—malignant glioma	0.000215	0.000475	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—PTPN11—malignant glioma	0.000215	0.000475	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NOTCH2—malignant glioma	0.000214	0.000472	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NOTCH2—malignant glioma	0.000214	0.000472	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—FGF2—malignant glioma	0.000213	0.000469	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—PIK3CD—malignant glioma	0.000212	0.000468	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—PIK3CD—malignant glioma	0.000212	0.000468	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000212	0.000467	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—PIK3CG—malignant glioma	0.000212	0.000467	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—KRAS—malignant glioma	0.000211	0.000465	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—PIK3CD—malignant glioma	0.000209	0.000462	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—KNG1—malignant glioma	0.000209	0.000462	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—KNG1—malignant glioma	0.000209	0.000462	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000205	0.000452	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—PPARG—malignant glioma	0.000204	0.00045	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—MMP3—malignant glioma	0.000201	0.000444	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—PIK3CB—malignant glioma	0.000201	0.000443	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—AKT2—malignant glioma	0.000201	0.000442	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—AKT2—malignant glioma	0.000201	0.000442	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CDKN2B—malignant glioma	0.0002	0.000441	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NTRK1—malignant glioma	0.000199	0.00044	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NTRK1—malignant glioma	0.000199	0.00044	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—MDM2—malignant glioma	0.000199	0.000439	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—RAF1—malignant glioma	0.000198	0.000437	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—ERBB2—malignant glioma	0.000196	0.000433	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—KRAS—malignant glioma	0.000194	0.000428	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PTK2—malignant glioma	0.000194	0.000428	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—PIK3CA—malignant glioma	0.000194	0.000428	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—PIK3CB—malignant glioma	0.000194	0.000427	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—CXCL8—malignant glioma	0.000193	0.000426	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—PIK3CD—malignant glioma	0.000193	0.000425	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—PIK3CD—malignant glioma	0.000193	0.000425	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—PTGS2—malignant glioma	0.000192	0.000423	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—HES1—malignant glioma	0.000191	0.00042	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NCOR1—malignant glioma	0.000189	0.000418	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—TP53—malignant glioma	0.000188	0.000414	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—RAF1—malignant glioma	0.000187	0.000412	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—PIK3CD—malignant glioma	0.000186	0.00041	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—MMP3—malignant glioma	0.000185	0.000409	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—MMP3—malignant glioma	0.000185	0.000409	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—PIK3CB—malignant glioma	0.000185	0.000408	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—PIK3CB—malignant glioma	0.000185	0.000408	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—IL2—malignant glioma	0.000185	0.000407	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CDKN2B—malignant glioma	0.000184	0.000405	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CDKN2B—malignant glioma	0.000184	0.000405	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—PIK3CB—malignant glioma	0.000182	0.000402	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PDGFRA—malignant glioma	0.000181	0.0004	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PTK2—malignant glioma	0.000178	0.000394	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PTK2—malignant glioma	0.000178	0.000394	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—PIK3CA—malignant glioma	0.000178	0.000393	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—CXCL8—malignant glioma	0.000178	0.000392	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—CXCL8—malignant glioma	0.000178	0.000392	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—SPP1—malignant glioma	0.000176	0.000388	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—HES1—malignant glioma	0.000175	0.000387	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—HES1—malignant glioma	0.000175	0.000387	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—CXCL8—malignant glioma	0.000175	0.000387	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NCOR1—malignant glioma	0.000174	0.000385	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NCOR1—malignant glioma	0.000174	0.000385	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—TP53—malignant glioma	0.000173	0.000381	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—RAF1—malignant glioma	0.000172	0.000379	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—RAF1—malignant glioma	0.000172	0.000379	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—COX8A—malignant glioma	0.00017	0.000375	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—IL2—malignant glioma	0.00017	0.000375	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—IL2—malignant glioma	0.00017	0.000375	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—PIK3CB—malignant glioma	0.000168	0.00037	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—PIK3CB—malignant glioma	0.000168	0.00037	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—IL2—malignant glioma	0.000168	0.00037	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—PTEN—malignant glioma	0.000167	0.000369	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TERT—malignant glioma	0.000167	0.000368	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PDGFRA—malignant glioma	0.000167	0.000368	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PDGFRA—malignant glioma	0.000167	0.000368	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PDGFB—malignant glioma	0.000163	0.000359	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—FGFR1—malignant glioma	0.000162	0.000358	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—SPP1—malignant glioma	0.000162	0.000358	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—SPP1—malignant glioma	0.000162	0.000358	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—PIK3CB—malignant glioma	0.000162	0.000358	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CXCL8—malignant glioma	0.000161	0.000356	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CXCL8—malignant glioma	0.000161	0.000356	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—PTGS2—malignant glioma	0.000161	0.000354	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—HIF1A—malignant glioma	0.00016	0.000352	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—AKT1—malignant glioma	0.000158	0.000349	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CAV1—malignant glioma	0.000154	0.000341	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—IL2—malignant glioma	0.000154	0.00034	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—IL2—malignant glioma	0.000154	0.00034	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TERT—malignant glioma	0.000154	0.000339	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TERT—malignant glioma	0.000154	0.000339	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—KDR—malignant glioma	0.000153	0.000337	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000152	0.000335	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PDGFB—malignant glioma	0.00015	0.000331	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PDGFB—malignant glioma	0.00015	0.000331	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—STAT3—malignant glioma	0.00015	0.00033	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—FGFR1—malignant glioma	0.000149	0.000329	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—FGFR1—malignant glioma	0.000149	0.000329	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—FN1—malignant glioma	0.000147	0.000324	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—F2—malignant glioma	0.000147	0.000324	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—HIF1A—malignant glioma	0.000147	0.000324	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—HIF1A—malignant glioma	0.000147	0.000324	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—AKT1—malignant glioma	0.000146	0.000321	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—BAD—malignant glioma	0.000145	0.00032	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ASMT—malignant glioma	0.000145	0.000319	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NOTCH1—malignant glioma	0.000144	0.000317	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CAV1—malignant glioma	0.000142	0.000313	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CAV1—malignant glioma	0.000142	0.000313	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000141	0.000312	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CD80—malignant glioma	0.000141	0.000311	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—APC—malignant glioma	0.000141	0.00031	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PIK3CG—malignant glioma	0.000141	0.00031	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—KDR—malignant glioma	0.000141	0.00031	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—KDR—malignant glioma	0.000141	0.00031	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—PTEN—malignant glioma	0.00014	0.000309	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—EGF—malignant glioma	0.000139	0.000307	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—MYC—malignant glioma	0.000139	0.000307	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PTPN11—malignant glioma	0.000138	0.000305	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—BCAN—malignant glioma	0.000136	0.0003	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—EGFR—malignant glioma	0.000136	0.0003	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—FN1—malignant glioma	0.000135	0.000298	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—F2—malignant glioma	0.000135	0.000298	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—FN1—malignant glioma	0.000135	0.000298	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—F2—malignant glioma	0.000135	0.000298	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—BAD—malignant glioma	0.000134	0.000295	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—BAD—malignant glioma	0.000134	0.000295	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NOTCH1—malignant glioma	0.000132	0.000292	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NOTCH1—malignant glioma	0.000132	0.000292	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—BRAF—malignant glioma	0.000132	0.000292	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CD80—malignant glioma	0.00013	0.000286	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CD80—malignant glioma	0.00013	0.000286	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PIK3CG—malignant glioma	0.000129	0.000286	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PIK3CG—malignant glioma	0.000129	0.000286	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—APC—malignant glioma	0.000129	0.000286	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—APC—malignant glioma	0.000129	0.000286	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—AKT2—malignant glioma	0.000129	0.000284	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—KRAS—malignant glioma	0.000128	0.000283	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—EGFR—malignant glioma	0.000128	0.000283	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—EGF—malignant glioma	0.000128	0.000282	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—EGF—malignant glioma	0.000128	0.000282	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PTPN11—malignant glioma	0.000127	0.000281	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PTPN11—malignant glioma	0.000127	0.000281	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PIK3CD—malignant glioma	0.000124	0.000273	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—PIK3CA—malignant glioma	0.000122	0.00027	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—BRAF—malignant glioma	0.000122	0.000268	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—BRAF—malignant glioma	0.000122	0.000268	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—KRAS—malignant glioma	0.000121	0.000267	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—AKT2—malignant glioma	0.000118	0.000261	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—AKT2—malignant glioma	0.000118	0.000261	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—FGF2—malignant glioma	0.000118	0.000261	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—PIK3CA—malignant glioma	0.000118	0.00026	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—EGFR—malignant glioma	0.000118	0.00026	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—EGFR—malignant glioma	0.000118	0.00026	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PIK3CD—malignant glioma	0.000114	0.000251	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PIK3CD—malignant glioma	0.000114	0.000251	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—PIK3CA—malignant glioma	0.000113	0.000249	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—PIK3CA—malignant glioma	0.000113	0.000249	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—KRAS—malignant glioma	0.000111	0.000246	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—KRAS—malignant glioma	0.000111	0.000246	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—PIK3CA—malignant glioma	0.000111	0.000245	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—MDM2—malignant glioma	0.000111	0.000244	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—RAF1—malignant glioma	0.00011	0.000244	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—IDH2—malignant glioma	0.00011	0.000242	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—ERBB2—malignant glioma	0.000109	0.000241	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—FGF2—malignant glioma	0.000109	0.00024	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—FGF2—malignant glioma	0.000109	0.00024	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PIK3CB—malignant glioma	0.000108	0.000238	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CXCL8—malignant glioma	0.000104	0.000228	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000103	0.000228	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CYP2B6—malignant glioma	0.000103	0.000227	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—PIK3CA—malignant glioma	0.000102	0.000226	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—PIK3CA—malignant glioma	0.000102	0.000226	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—MDM2—malignant glioma	0.000102	0.000225	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—MDM2—malignant glioma	0.000102	0.000225	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—RAF1—malignant glioma	0.000102	0.000224	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—RAF1—malignant glioma	0.000102	0.000224	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—ERBB2—malignant glioma	0.000101	0.000222	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—ERBB2—malignant glioma	0.000101	0.000222	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—AKT1—malignant glioma	0.0001	0.000221	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PIK3CB—malignant glioma	9.92e-05	0.000219	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PIK3CB—malignant glioma	9.92e-05	0.000219	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CASP3—malignant glioma	9.91e-05	0.000219	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IL2—malignant glioma	9.9e-05	0.000218	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—PIK3CA—malignant glioma	9.88e-05	0.000218	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—AKT1—malignant glioma	9.64e-05	0.000213	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CXCL8—malignant glioma	9.53e-05	0.00021	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CXCL8—malignant glioma	9.53e-05	0.00021	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—IDH1—malignant glioma	9.43e-05	0.000208	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—MMP9—malignant glioma	9.37e-05	0.000207	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PTEN—malignant glioma	9.31e-05	0.000205	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—AKT1—malignant glioma	9.21e-05	0.000203	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—AKT1—malignant glioma	9.21e-05	0.000203	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CASP3—malignant glioma	9.12e-05	0.000201	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CASP3—malignant glioma	9.12e-05	0.000201	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—SPHK1—malignant glioma	9.12e-05	0.000201	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IL2—malignant glioma	9.11e-05	0.000201	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IL2—malignant glioma	9.11e-05	0.000201	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—AKT1—malignant glioma	9.09e-05	0.0002	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CYP2C18—malignant glioma	8.94e-05	0.000197	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—MMP9—malignant glioma	8.62e-05	0.00019	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—MMP9—malignant glioma	8.62e-05	0.00019	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PTEN—malignant glioma	8.57e-05	0.000189	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PTEN—malignant glioma	8.57e-05	0.000189	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	8.43e-05	0.000186	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—VEGFA—malignant glioma	8.41e-05	0.000186	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—AKT1—malignant glioma	8.36e-05	0.000184	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—AKT1—malignant glioma	8.36e-05	0.000184	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—STAT3—malignant glioma	8.33e-05	0.000184	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—AKT1—malignant glioma	8.07e-05	0.000178	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—VEGFA—malignant glioma	7.74e-05	0.000171	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—VEGFA—malignant glioma	7.74e-05	0.000171	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—MYC—malignant glioma	7.74e-05	0.000171	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	7.67e-05	0.000169	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—STAT3—malignant glioma	7.67e-05	0.000169	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—STAT3—malignant glioma	7.67e-05	0.000169	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—EGFR—malignant glioma	7.57e-05	0.000167	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	7.41e-05	0.000163	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GSTT1—malignant glioma	7.23e-05	0.000159	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—KRAS—malignant glioma	7.15e-05	0.000158	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—MYC—malignant glioma	7.12e-05	0.000157	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—MYC—malignant glioma	7.12e-05	0.000157	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—EGFR—malignant glioma	6.97e-05	0.000154	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—EGFR—malignant glioma	6.97e-05	0.000154	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PTGS1—malignant glioma	6.77e-05	0.000149	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	6.75e-05	0.000149	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—KRAS—malignant glioma	6.58e-05	0.000145	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—KRAS—malignant glioma	6.58e-05	0.000145	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PIK3CA—malignant glioma	6.57e-05	0.000145	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TP53—malignant glioma	6.36e-05	0.00014	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—BCHE—malignant glioma	6.3e-05	0.000139	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—SLC5A5—malignant glioma	6.22e-05	0.000137	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PIK3CA—malignant glioma	6.05e-05	0.000133	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PIK3CA—malignant glioma	6.05e-05	0.000133	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	5.88e-05	0.00013	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TP53—malignant glioma	5.85e-05	0.000129	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TP53—malignant glioma	5.85e-05	0.000129	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.83e-05	0.000129	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—AKT1—malignant glioma	5.37e-05	0.000118	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.08e-05	0.000112	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GSTP1—malignant glioma	5.01e-05	0.00011	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—AKT1—malignant glioma	4.94e-05	0.000109	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—AKT1—malignant glioma	4.94e-05	0.000109	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CAT—malignant glioma	4.87e-05	0.000108	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—NCOR1—malignant glioma	4.6e-05	0.000102	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CAV1—malignant glioma	3.75e-05	8.28e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.59e-05	7.91e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PIK3CG—malignant glioma	3.42e-05	7.54e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PPARG—malignant glioma	3.3e-05	7.28e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PIK3CD—malignant glioma	3e-05	6.63e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PIK3CB—malignant glioma	2.62e-05	5.78e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PTGS2—malignant glioma	2.6e-05	5.72e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PTEN—malignant glioma	2.26e-05	4.99e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PIK3CA—malignant glioma	1.6e-05	3.52e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—AKT1—malignant glioma	1.3e-05	2.88e-05	CbGpPWpGaD
